Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients with Hematologic Malignancies

Trial Profile

Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients with Hematologic Malignancies

Completed
Phase of Trial: Phase I/II

Latest Information Update: 02 May 2017

At a glance

  • Drugs TZ 101 (Primary)
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Chronic lymphocytic leukaemia; Haematological malignancies; Hodgkin's disease; Myelodysplastic syndromes; Non-Hodgkin's lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Apr 2017 Status changed from active, no longer recruiting to completed.
    • 10 Jan 2017 Status changed from recruiting to active, no longer recruiting.
    • 03 May 2016 Status changed from active, no longer recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top